<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="wtpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4082405/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genetic variation in protein specific antigen detected prostate cancer and the effect of control selection on genetic association studies</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082405/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"><meta name="citation_title" content="Genetic variation in protein specific antigen detected prostate cancer and the effect of control selection on genetic association studies"><meta name="citation_authors" content="Duleeka W Knipe, David M Evans, John P. Kemp, Rosalind Eeles, Douglas F Easton, Zsofia Kote-Jarai, Ali Amin Al Olama, Sara Benlloch, Jenny L. Donovan, Freddie C. Hamdy, David E Neal, George Davey Smith, Mark Lathrop, Richard M Martin"><meta name="citation_date" content="July 2014"><meta name="citation_issue" content="7"><meta name="citation_volume" content="23"><meta name="citation_firstpage" content="1356"><meta name="citation_doi" content="10.1158/1055-9965.EPI-13-0889"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4082405/?report=abstract"><meta name="citation_pmid" content="24753544"><meta name="DC.Title" content="Genetic variation in protein specific antigen detected prostate cancer and the effect of control selection on genetic association studies"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Europe PMC Funders"><meta name="DC.Contributor" content="Duleeka W Knipe"><meta name="DC.Contributor" content="David M Evans"><meta name="DC.Contributor" content="John P. Kemp"><meta name="DC.Contributor" content="Rosalind Eeles"><meta name="DC.Contributor" content="Douglas F Easton"><meta name="DC.Contributor" content="Zsofia Kote-Jarai"><meta name="DC.Contributor" content="Ali Amin Al Olama"><meta name="DC.Contributor" content="Sara Benlloch"><meta name="DC.Contributor" content="Jenny L. Donovan"><meta name="DC.Contributor" content="Freddie C. Hamdy"><meta name="DC.Contributor" content="David E Neal"><meta name="DC.Contributor" content="George Davey Smith"><meta name="DC.Contributor" content="Mark Lathrop"><meta name="DC.Contributor" content="Richard M Martin"><meta name="DC.Date" content="2014 Jul"><meta name="DC.Identifier" content="10.1158/1055-9965.EPI-13-0889"><meta name="DC.Language" content="en"><meta property="og:title" content="Genetic variation in protein specific antigen detected prostate cancer and the effect of control selection on genetic association studies"><meta property="og:type" content="article"><meta property="og:description" content="Only a minority of the genetic component of prostate cancer (PrCa) risk has been explained. Some observed associations of single nucleotide polymorphisms (SNPs) with PrCa might arise from associations of these SNPs with circulating prostate specific antigen ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082405/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-wtpa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4082405/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4082405/pdf/emss-58112.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8B1601DD5693010000000006C303FD.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4082405%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=epmc%20author%20manuscript[filter]" class="navlink">Europe PMC Author Manuscripts</a></li><li class="accid">PMC4082405</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-wtpa2.gif" alt="Logo of wtpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="395,0,500,52" alt="Europe PMC" title="Europe PMC" href="http://europepmc.org/" ref="reftype=publisher&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,394,52" alt="Europe PMC Funders Group" title="Europe PMC Funders Group" href="http://europepmc.org/Funders/" ref="reftype=publisher&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="53,0,500,75" alt="Submit a Manuscript" title="Submit a Manuscript" href="https://plus.europepmc.org" ref="reftype=publisher&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Cancer Epidemiol Biomarkers Prev</a></span>. Author manuscript; available in PMC 2015 Jan 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24753544" target="pmc_ext" ref="reftype=publisher&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access"><span class="cit">Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7): 1356–1365. </span></a></div><span class="fm-vol-iss-date">Published online 2014 Apr 21. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1158%2F1055-9965.EPI-13-0889" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1158/1055-9965.EPI-13-0889</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4082405</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">EMSID: </span><span>EMS58112</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/24753544">24753544</a></div></div></div></div><h1 class="content-title">Genetic variation in protein specific antigen detected prostate cancer and the effect of control selection on genetic association studies</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Knipe%20DW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300943966576" co-class="co-affbox">Duleeka W Knipe</a>,<sup>1,</sup><sup>**</sup> <a href="/pubmed/?term=Evans%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300942970784" co-class="co-affbox">David M Evans</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Kemp%20JP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300946990000" co-class="co-affbox">John P. Kemp</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Eeles%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300940497968" co-class="co-affbox">Rosalind Eeles</a>,<sup>3,</sup><sup>4</sup> <a href="/pubmed/?term=Easton%20DF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300940823424" co-class="co-affbox">Douglas F Easton</a>,<sup>5</sup> <a href="/pubmed/?term=Kote-Jarai%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300935765776" co-class="co-affbox">Zsofia Kote-Jarai</a>,<sup>3,</sup><sup>4</sup> <a href="/pubmed/?term=Al%20Olama%20AA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300979106192" co-class="co-affbox">Ali Amin Al Olama</a>,<sup>5</sup> <a href="/pubmed/?term=Benlloch%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300935711728" co-class="co-affbox">Sara Benlloch</a>,<sup>5</sup> <a href="/pubmed/?term=Donovan%20JL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300935709744" co-class="co-affbox">Jenny L. Donovan</a>,<sup>1</sup> <a href="/pubmed/?term=Hamdy%20FC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300945872656" co-class="co-affbox">Freddie C. Hamdy</a>,<sup>6</sup> <a href="/pubmed/?term=Neal%20DE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300941567168" co-class="co-affbox">David E Neal</a>,<sup>4,</sup><sup>7</sup> <a href="/pubmed/?term=Smith%20GD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300937927408" co-class="co-affbox">George Davey Smith</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Lathrop%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300982435264" co-class="co-affbox">Mark Lathrop</a>,<sup>#</sup><sup>8,</sup><sup>9</sup> and  <a href="/pubmed/?term=Martin%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544" class="affpopup" co-rid="_co_idm140300945751216" co-class="co-affbox">Richard M Martin</a><sup>#</sup><sup>1,</sup><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140300943966576"><h3 class="no_margin">Duleeka W Knipe</h3><p><sup>1</sup>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Knipe%20DW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Duleeka W Knipe</a></div></div><div id="_co_idm140300942970784"><h3 class="no_margin">David M Evans</h3><p><sup>1</sup>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom </p><p><sup>2</sup>MRC / University of Bristol Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Evans%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">David M Evans</a></div></div><div id="_co_idm140300946990000"><h3 class="no_margin">John P. Kemp</h3><p><sup>1</sup>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom </p><p><sup>2</sup>MRC / University of Bristol Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Kemp%20JP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">John P. Kemp</a></div></div><div id="_co_idm140300940497968"><h3 class="no_margin">Rosalind Eeles</h3><p><sup>3</sup>The Institute of Cancer Research, Sutton, Surrey, UK </p><p><sup>4</sup>The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey and London, UK </p><div>Find articles by <a href="/pubmed/?term=Eeles%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Rosalind Eeles</a></div></div><div id="_co_idm140300940823424"><h3 class="no_margin">Douglas F Easton</h3><p><sup>5</sup>Cancer Research UK Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Cambridge, UK </p><div>Find articles by <a href="/pubmed/?term=Easton%20DF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Douglas F Easton</a></div></div><div id="_co_idm140300935765776"><h3 class="no_margin">Zsofia Kote-Jarai</h3><p><sup>3</sup>The Institute of Cancer Research, Sutton, Surrey, UK </p><p><sup>4</sup>The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey and London, UK </p><div>Find articles by <a href="/pubmed/?term=Kote-Jarai%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Zsofia Kote-Jarai</a></div></div><div id="_co_idm140300979106192"><h3 class="no_margin">Ali Amin Al Olama</h3><p><sup>5</sup>Cancer Research UK Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Cambridge, UK </p><div>Find articles by <a href="/pubmed/?term=Al%20Olama%20AA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Ali Amin Al Olama</a></div></div><div id="_co_idm140300935711728"><h3 class="no_margin">Sara Benlloch</h3><p><sup>5</sup>Cancer Research UK Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Cambridge, UK </p><div>Find articles by <a href="/pubmed/?term=Benlloch%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Sara Benlloch</a></div></div><div id="_co_idm140300935709744"><h3 class="no_margin">Jenny L. Donovan</h3><p><sup>1</sup>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Donovan%20JL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Jenny L. Donovan</a></div></div><div id="_co_idm140300945872656"><h3 class="no_margin">Freddie C. Hamdy</h3><p><sup>6</sup>Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Hamdy%20FC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Freddie C. Hamdy</a></div></div><div id="_co_idm140300941567168"><h3 class="no_margin">David E Neal</h3><p><sup>4</sup>The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey and London, UK </p><p><sup>7</sup>Department of Oncology, University of Cambridge, Cambridge, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Neal%20DE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">David E Neal</a></div></div><div id="_co_idm140300937927408"><h3 class="no_margin">George Davey Smith</h3><p><sup>1</sup>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom </p><p><sup>2</sup>MRC / University of Bristol Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Smith%20GD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">George Davey Smith</a></div></div><div id="_co_idm140300982435264"><h3 class="no_margin">Mark Lathrop</h3><p><sup>8</sup>Commissariat à l‘Energie Atomique, Center National de Génotypage, Evry, France </p><p><sup>9</sup>McGill University-Génome Québec Innovation Centre, Montreal, Canada </p><div>Find articles by <a href="/pubmed/?term=Lathrop%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Mark Lathrop</a></div></div><div id="_co_idm140300945751216"><h3 class="no_margin">Richard M Martin</h3><p><sup>1</sup>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom </p><p><sup>2</sup>MRC / University of Bristol Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom </p><div>Find articles by <a href="/pubmed/?term=Martin%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24753544">Richard M Martin</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140300945801728_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140300945801728_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140300945801728_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom </div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>MRC / University of Bristol Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom </div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>The Institute of Cancer Research, Sutton, Surrey, UK </div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey and London, UK </div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Cancer Research UK Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Cambridge, UK </div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom </div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Department of Oncology, University of Cambridge, Cambridge, United Kingdom </div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Commissariat à l‘Energie Atomique, Center National de Génotypage, Evry, France </div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>McGill University-Génome Québec Innovation Centre, Montreal, Canada </div><div><sup>#</sup>Contributed equally.</div><div id="CR1"><sup>**</sup><strong>Corresponding Author</strong>: Duleeka W Knipe, School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, Tel. 0117 928 7302, Fax. 0117 928 7325, <a href="mailto:dev@null" data-email="ku.ca.lotsirb@epink.eed" class="oemail">ku.ca.lotsirb@epink.eed</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140300945801728_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24753544" target="pmc_ext" ref="reftype=publisher&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Cancer Epidemiol Biomarkers Prev</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC4082405/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC4082405/bin/NIHMS58112-supplement-1.pdf" data-ga-action="click_feat_suppl">NIHMS58112-supplement-1.pdf</a><span style="color:gray"> (700K)</span></div><div class="small guid">GUID:&nbsp;55FF6AAD-6B4D-462C-AE65-1A2CB7FDB0A7</div></div></dd></dl></div><div id="idm140300978493584" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140300978493584title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Background</h3><p id="P1" class="p p-first-last">Only a minority of the genetic component of prostate cancer (PrCa) risk has been explained. Some observed associations of single nucleotide polymorphisms (SNPs) with PrCa might arise from associations of these SNPs with circulating prostate specific antigen (PSA) because PSA values are used to select controls.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods</h3><p id="P2" class="p p-first-last">We undertook a genome-wide association study (GWAS) of screen detected PrCa (ProtecT 1146 cases and 1804 controls); meta-analysed the results with those from the previously published UK Genetic Prostate Cancer Study (1854 cases and 1437 controls); investigated associations of SNPs with PrCa using either ‘low’ (PSA &lt;0.5ng/ml) or ‘high’ (PSA ≥3ng/ml, biopsy negative) PSA controls; and investigated associations of SNPs with PSA.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">The ProtecT GWAS confirmed previously reported associations of PrCa at 3 loci: 10q11.23, 17q24.3 and 19q13.33. The meta-analysis confirmed associations of PrCa with SNPs near 4 previously identified loci (8q24.21,10q11.23, 17q24.3 and 19q13.33). When comparing PrCa cases with low PSA controls, alleles at genetic markers rs1512268, rs445114, rs10788160, rs11199874, rs17632542, rs266849 and rs2735839 were associated with an increased risk of PrCa, but the effect-estimates were attenuated to the null when using high PSA controls (p for heterogeneity in effect-estimates&lt;0.04). We found a novel inverse association of rs9311171-T with circulating PSA.</p></div><div id="S4" class="sec"><h3 id="S4title">Conclusions</h3><p id="P4" class="p p-first-last">Differences in effect estimates for PrCa observed when comparing low vs. high PSA controls, may be explained by associations of these SNPs with PSA.</p></div><div id="S5" class="sec sec-last"><h3 id="S5title">Impact</h3><p id="P5" class="p p-first-last">These findings highlight the need for inferences from genetic studies of PrCa risk to carefully consider the influence of control selection criteria.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Prostate Specific Antigen, research design, prostate cancer, case-control studies, genome wide association studies</span></div></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Introduction</h2><p id="P6" class="p p-first">Prostate cancer (PrCa) is the leading cause of cancer in men in developed countries, accounting for 25% of new cancer cases. Prostate-specific antigen (PSA) testing is currently the most widely used screening test for PrCa, but it is limited because current thresholds defining raised levels (typically circulating PSA levels &gt; 3 or 4 ng/ml) do not distinguish clinically important from indolent cancer, and lower levels do not exclude PrCa(<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381165">1</a>).</p><p id="P7">Epidemiological studies suggest a significant genetic component in the aetiology of the disease, but only 30% of the estimated heritability has so far been explained (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381131">2</a>), highlighting the need for more studies to identify the full genetic profile of PrCa. The majority of genome-wide association studies (GWAS) of PrCa have been based on clinically-detected cases (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381143">3</a>-<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381127">11</a>), with some studies specifically focusing on young age at onset, and/or familial or aggressive PrCa (i.e. pathological stage T3/T4,N+,M+, Gleason score ≥ 7, grade III, metastases, androgen ablation therapy, or PSA at least 10-50 ng/ml) (<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381159">4</a>-<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381128">6</a>, <a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381149">8</a>-<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381133">10</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381130">12</a>). Most studies have compared cases to controls that have been selected on the basis of PSA levels under a certain threshold (<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381152">5</a>, <a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381168">6</a>, <a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381169">10</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381147">12</a>-<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381144">17</a>); including some studies which have used controls with extremely low PSA levels (&lt;0.5ng/ml; “supernormal” controls) (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381160">3</a>, <a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381162">5</a>, <a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381150">6</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381155">12</a>, <a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381138">15</a>). Such control selection strategies can make it difficult to interpret associations between a genetic variant and disease, since such associations may result from a relationship between the variant and PSA levels rather than PrCa. A limited number of GWAS have attempted to clarify this relationship by analysing associations of PSA levels with genetic markers identified using PSA screened controls (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381171">2</a>, <a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381156">5</a>, <a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381163">6</a>, <a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381129">15</a>, <a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381126">18</a>, <a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794936">19</a>). It has been shown that SNPs at 13 known prostate cancer susceptibility loci (rs6869841, rs1270884, rs17632542, rs2242652, rs6983561, rs620861, rs10090154, rs7837688, rs12500426, rs7127900, rs10993994, rs2659056, rs2735839, rs5945619) are also associated with PSA concentration in blood in controls (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381141">2</a>, <a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381151">5</a>, <a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381167">6</a>, <a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381170">15</a>, <a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794938">19</a>). As controls were defined by a PSA cut-off, however, associations between genotypes and the full distribution of PSA in men without PrCa could not be assessed. Only one study specifically investigated the relationship between genetic variants and circulating PSA level in men without detected PrCa (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794937">19</a>). The Prostate Testing for cancer and Treatment study (ProtecT) contributed replication data to this study for the significant SNPs identified in the discovery GWAS. Genome wide significant associations between PSA levels and markers at 6 different loci were reported (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794941">19</a>).</p><p id="P8" class="p p-last">Our investigation had three aims. Firstly, to conduct a GWAS in a population-based screen detected PrCa population (ProtecT)(<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381142">20</a>). Secondly to conduct a meta-analysis to combine the results of the ProtecT GWAS with the previously published UK Genetic Prostate Cancer Study (UKGPCS)(<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381154">6</a>). Thirdly, to investigate whether previously identified associations of genetic variants with PrCa could be explained by associations with PSA levels, rather than cancer <em>per se</em>. For the third aim we: i) identified previously published PrCa risk single nucleotide polymorphisms (SNPs) and compared their association with PrCa in two case-control studies nested within ProtecT; the first compared PrCa cases (diagnosed following a PSA ≥3 ng/ml and a positive biopsy) with ‘low’ PSA controls (PSA &lt;0.5 ng/ml) and the second compared PrCa cases with ‘high’ PSA controls (PSA ≥3 ng/ml and a negative biopsy); our hypothesis was that if the genetic marker is associated with PSA level and not PrCa, then the effect estimates would be greatest when using the low PSA controls and close to the null when using the high PSA controls; and ii) examined the relationship of each of the identified genetic markers with PSA level as a continuous variable in controls selected independently of PSA level (“unrestricted” controls), including those with PSA levels ≥3 ng/ml who were biopsy negative, as well as those with levels below 3 ng/ml.</p></div><div id="S7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S7title">Materials and Methods</h2><div id="S8" class="sec sec-first"><h3 id="S8title">Samples</h3><p id="P9" class="p p-first">Two study populations were used in this analysis. Firstly participants from the Prostate Testing for cancer and Treatment (ProtecT) study(<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381164">20</a>), and secondly the UK Genetic Prostate Cancer Study stage I (UKGPCS), both of European ancestry(<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381140">6</a>). The ProtecT study recruited all men aged 50-69 years between 2001-2009 from 337 general practices in nine UK centres (Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Leeds, Leicester, Newcastle and Sheffield). All men were invited to a prostate check clinic and were offered a PSA test: approximately 110,000 attended. For those with a PSA level of ≥3ng/ml, a transrectal ultrasound guided prostate biopsy was conducted. All detected tumours were histologically confirmed and assigned a Gleason score by a specialist uropathologist following a standard proforma. Tumours were categorised as low (score &lt;7), mid (score=7) or high (score&gt;7) grade. Clinical staging was assigned using the TNM system(<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381153">21</a>) as either localised (T1-T2) or advanced (T3-T4) (although most in the latter category were locally advanced and few tumours had metastasized distally). Approximately 3000 men were diagnosed with PrCa between 2001 and 2009. All men diagnosed with PrCa after attending a prostate check clinic before end November 2006 (and their matched controls) were eligible for inclusion in the current ProtecT GWAS (n=1215 cases).</p><p id="P10">Men with no evidence of PrCa were eligible for selection as controls (approximate n=107,000); these were men with a PSA&lt;3ng/ml or a PSA≥3ng/ml with the most recent biopsy being negative. Controls were stratum matched to the genotyped PrCa cases by age, GP practice and calendar time period, in two distinct rounds of matching. In the first round a random sample of 6 controls per case were selected from all eligible controls in each age and GP practice strata (“unrestricted” controls); as the prostate check clinics were completed in one GP practice before moving to the next, matching on GP practice also matched on calendar time period. The second round randomly selected 1 control with a PSA&lt;0.5ng/ml (and with whole blood collected) per case from the same age and GP practice strata as the index case (‘supernormal controls’). A total of 1925 matched controls were eligible for inclusion in the current GWAS. Trent Multicenter Research Ethics Committee (MREC) approved the ProtecT study (MREC/01/4/025) and the associated ProMPT study which collected biological material (MREC/01/4/061), and written informed consent was obtained.</p><p id="P11" class="p p-last">The UKGPCS (stage I) dataset has been previously described (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381166">6</a>). Briefly the cases (n=2017) were clinically detected and selected if the man had a diagnosis at ≤60 years of age or a first/second degree family history of PrCa. Self-reported “non-white” men were excluded, as were those who were diagnosed through asymptomatic screening. UKGPCS controls (total n = 1893) were solely selected from men in the ProtecT study who had a PSA &lt;0.5ng/ml. In the current meta-analysis, we excluded from the UKGPCS results those men who were in the ProtecT GWAS control series described above (n=456) so that the populations in the pooled analysis were independent samples (<a href="/pmc/articles/PMC4082405/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4082405/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140300939911760" class="figure"><a href="/pmc/articles/PMC4082405/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4082405_emss-58112-f0001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is emss-58112-f0001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4082405/bin/emss-58112-f0001.jpg"></a></div><div id="largeobj_idm140300939911760" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4082405/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4082405/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p3">Venn Diagram showing the inclusion of controls in the ProtecT and UKGPCS GWAS</p><p id="__p4">* Controls overlapping between control populations were excluded from the UKGPCS GWAS</p></div></div></div></div><div id="S9" class="sec"><h3 id="S9title">Genotyping in ProtecT</h3><p id="P12" class="p p-first">The genotyping was performed at the Center National de Genotypage, Evry, France using the Illumina Human660W-Quad_v1_A array (Illumina, Inc., San Diego, CA). Quality control measures included exclusions for sex-mismatches, minimal (&lt;0.325) or excessive heterozygosity (&gt;0.345), cryptic relatedness as estimated by proportion of loci identical by descent (IBD&gt;0.1), and disproportionate levels of individual missingness (&gt;3%). Individuals were then checked for evidence of population stratification by multidimensional scaling analysis and compared with HapMap II (release 22) European descent (CEU), Han Chinese (CHB), Japanese (JPT) and Yoruba (YRI) reference populations. Individuals showing evidence of non-European ancestry were removed. SNPs with a minor allele frequency of below 1%, a call rate of &lt;95% or evidence for violation of Hardy-Weinberg equilibrium (p&lt;5 × 10<sup>−7</sup>) were discarded.</p><p id="P13" class="p p-last">Imputation of autosomal genotypic data used Markov Chain Haplotyping software (MACH v.1.0.16(<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381157">22</a>)) and phased haplotype data from CEU individuals (HapMap release 22, Phase II NCBI B36, dbSNP 126) on 514,432 autosomal SNPs. All SNPs with poor imputation quality (r<sup>2</sup> hat &lt;0.3) were removed. The final working dataset included 2950 individuals (cases n=1146, controls n=1804). A total of 1272 controls were included from the first round of “unrestricted” control selection (PSA &lt;0.5ng/ml n=238; PSA ≥0.5 and PSA&lt;3ng/ml n=941; PSA≥3ng/ml n=93) and a further 532 from the second round (“supernormal” control selection).</p></div><div id="S10" class="sec"><h3 id="S10title">UKGPCS genotyping</h3><p id="P14" class="p p-first-last">This has been reported elsewhere (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381146">6</a>). Briefly genotypes were generated using the Illumina Infinium HumanHap550 array, and we only used genotypes with a call rate of &gt;97%. Related samples and those with Asian/African ancestry were excluded. After exclusions, 1,854 cases and 1,437 controls (independent of ProtecT – see <a href="/pmc/articles/PMC4082405/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>) were used in the current meta-analysis.</p></div><div id="S11" class="sec sec-last"><h3 id="S11title">Statistical Analysis</h3><p id="P15" class="p p-first">The statistical analysis was undertaken in four stages (see <a href="/pmc/articles/PMC4082405/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). In the first stage, a genome-wide association analysis was performed on the ProtecT samples using the software package MACH2DAT(<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381132">22</a>, <a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794939">23</a>), employing a logistic regression model based on an expected allelic dosage model for SNPs. Associations between each SNP and disease were assessed by a Wald test and a p-value of &lt; 5 × 10<sup>−8</sup> was considered genome-wide significant. All estimates are reported in the direction of the risk allele.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC4082405/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140300939917616" class="figure"><a href="/pmc/articles/PMC4082405/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4082405_emss-58112-f0002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is emss-58112-f0002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4082405/bin/emss-58112-f0002.jpg"></a></div><div id="largeobj_idm140300939917616" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4082405/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC4082405/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p5">Analysis strategy</p><p id="__p6">* Population</p><p id="__p7">** Ratio of Odds Ratios</p></div></div></div><p id="P16">In the second stage, we meta-analysed the top SNPs identified in ProtecT with the UKGPCS dataset. A total of 381 SNPs reaching a threshold for suggestive significance of 5 × 10<sup>−5</sup> in the ProtecT GWAS were included in the meta-analysis. The threshold level of 5 × 10<sup>−5</sup> was a pragmatic choice, based on similar thresholds for suggestive significance cited in the literature, because of the relatively small sample size in ProtecT. Using a fixed effect inverse variance model, the β-coefficients and standard errors from ProtecT and UKGPCS were combined using the <em>metan</em> command in STATA. A p-value of 5 × 10<sup>−8</sup> was used to identify genome-wide significant SNPs in the meta-analysis. Heterogeneity between the ProtecT and UKGPCS studies was evaluated using Cochran‘s Q statistic and the I<sup>2</sup> value(<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381158">24</a>). The two studies had the same strand orientation and used the same effect alleles. Associations showing moderate-high levels of heterogeneity (I<sup>2</sup>&gt;50) were investigated further to determine whether the heterogeneity could be explained by the difference in control or case populations used in ProtecT and UKGPCS. We did this in two stages: first, we used only the low PSA (&lt;0.5 ng/ml) controls in ProtecT to generate new effect estimates and re-ran the meta-analysis for those SNPs showing moderate-high levels of heterogeneity in the original analysis; second, for those SNPs which still showed moderate-high levels of heterogeneity, we restricted the ProtecT cases to include only young cases (≤60 years of age) and/or those with a family history and re-ran the meta-analysis.</p><p id="P17">In stage 3 we investigated how the choice of controls in case-control GWAS studies may have impacted on associations of SNPs with PrCa, using two control populations from the ProtecT study: 770 low PSA controls (PSA &lt;0.5 ng/ml, from both the “unrestricted” control selection, n=238, and “supernormal” control selection, n=532); and 93 ‘high’ PSA controls (PSA ≥3ng/ml). We also did a sensitivity analysis relaxing the ‘high’ PSA control threshold to a PSA level ≥ 2ng/ml, resulting in 250 ‘high’ PSA controls. We did this in order to increase power and move our high control population towards a more general population. We generated a list of SNPs to be tested by downloading all published SNPs associated with both PrCa risk and PSA level from the catalogue of Published Genome-wide Association Studies (<a href="http://www.genome.gov/gwastudies/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.genome.gov/gwastudies/</a>: downloaded 21/11/2012). We supplemented this list with additional SNPs associated with PrCa in a recent meta-analysis (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381136">2</a>), resulting in a total of 83 SNPs. Using this list we extracted the individual genotypic data for all participants in our ProtecT dataset, although two SNPs were neither genotyped nor imputed (rs7210100 and rs16902094). Using the genotypic data we generated effect estimates for each SNP using multinomial logistic regression, where each control group (low and high) was compared to cases separately (<a href="/pmc/articles/PMC4082405/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). To test the null hypothesis, that there was no difference between the two control groups when used to estimate the odds ratios for the associations of SNPs with PrCa, we carried out a separate logistic regression model that tested the association of each SNP with control type (low vs. high); this is same as testing whether the ratio of odds ratios using the two control groups were equivalent (i.e. equal to 1), as the base case group would be cancelled out (<a href="/pmc/articles/PMC4082405/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>).</p><p id="P18">Finally we conducted a regression analysis of SNPs on PSA level within the “unrestricted” control population (controls selected independent of PSA level). PSA values were log-transformed to approximate a normal distribution. To account for the multiple comparisons between PSA levels and SNP markers, we only highlight findings which showed evidence of an association in both the stratified analysis and a complementary association in the regression analysis.</p><p id="P19" class="p p-last">The anti-log of the β was taken to estimate the percentage change in PSA level by increasing allele dose. In order to incorporate the uncertainty of the imputation process, expected allelic dosage data were used for the analysis. Genotypic dosages are the expected number of copies of an allele which ranges from 0-2. For genotyped SNPs the exact number of copies of an allele is known, but for imputed SNPs the estimate maybe less precise.</p></div></div><div id="S12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S12title">Results</h2><div id="S13" class="sec sec-first"><h3 id="S13title">Genome-wide association study in ProtecT (stage 1)</h3><p id="P20" class="p p-first-last">The study characteristics of those individuals (cases n=1146, controls n=1804) included in the ProtecT GWAS are presented in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>. <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a> shows the quantile-quantile (Q-Q) plot of the distribution of test statistics for comparison of genotype frequencies in cases versus controls. The lambda inflation factor was 1.025. In the GWAS, 381 SNPs were associated with PrCa at P&lt;5 × 10<sup>−5</sup> (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 2</a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 2</a>). We detected a genome-wide significant association (P&lt;5 × 10<sup>−8</sup>) between PrCa and SNPs at 3 previously identified loci: 10q11.23 (rs10993994), 17q24.3(rs7222314) and 19q13.33(rs1058205) (<a href="/pmc/articles/PMC4082405/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> and Locus Zoom plots in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figures 3-5</a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p8">Results of independent SNPs reaching genome wide significance (P&lt;5 × 10<sup>−8</sup>) in the ProtecT GWAS</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140300936821984" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">Loci</th><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="left">Chromosome</th><th rowspan="1" colspan="1" valign="top" align="left">Position</th><th rowspan="1" colspan="1" valign="top" align="left">Alleles</th><th rowspan="1" colspan="1" valign="top" align="left">
β
<sup><sup>a</sup></sup>
</th><th rowspan="1" colspan="1" valign="top" align="left">SE<sup><sup>b</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="left">OR<sup><sup>c</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="left">P-value</th><th rowspan="1" colspan="1" valign="top" align="left">EAF<sup><sup>d</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="left">RSQR<sup><sup>e</sup></sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">10q11.23</td><td rowspan="1" colspan="1" valign="top" align="left">rs10993994</td><td rowspan="1" colspan="1" valign="top" align="right">10</td><td rowspan="1" colspan="1" valign="top" align="left">51219502</td><td rowspan="1" colspan="1" valign="top" align="left">T/C</td><td rowspan="1" colspan="1" valign="top" align="left">0.33</td><td rowspan="1" colspan="1" valign="top" align="left">0.06</td><td rowspan="1" colspan="1" valign="top" align="left">1.39</td><td rowspan="1" colspan="1" valign="top" align="left">1.58 × 10<sup>−09</sup></td><td rowspan="1" colspan="1" valign="top" align="left">0.5983</td><td rowspan="1" colspan="1" valign="top" align="right">0.9793</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">17q24.3</td><td rowspan="1" colspan="1" valign="top" align="left">rs7222314</td><td rowspan="1" colspan="1" valign="top" align="right">17</td><td rowspan="1" colspan="1" valign="top" align="left">66616533</td><td rowspan="1" colspan="1" valign="top" align="left">A/G</td><td rowspan="1" colspan="1" valign="top" align="left">0.32</td><td rowspan="1" colspan="1" valign="top" align="left">0.06</td><td rowspan="1" colspan="1" valign="top" align="left">1.38</td><td rowspan="1" colspan="1" valign="top" align="left">8.59 × 10<sup>−09</sup></td><td rowspan="1" colspan="1" valign="top" align="left">0.4772</td><td rowspan="1" colspan="1" valign="top" align="right">0.9295</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">19q13.33</td><td rowspan="1" colspan="1" valign="top" align="left">rs1058205</td><td rowspan="1" colspan="1" valign="top" align="right">19</td><td rowspan="1" colspan="1" valign="top" align="left">56055210</td><td rowspan="1" colspan="1" valign="top" align="left">T/C</td><td rowspan="1" colspan="1" valign="top" align="left">0.40</td><td rowspan="1" colspan="1" valign="top" align="left">0.07</td><td rowspan="1" colspan="1" valign="top" align="left">1.49</td><td rowspan="1" colspan="1" valign="top" align="left">4.63 × 10<sup>−08</sup></td><td rowspan="1" colspan="1" valign="top" align="left">0.1828</td><td rowspan="1" colspan="1" valign="top" align="right">1</td></tr></tbody></table></div><div id="largeobj_idm140300936821984" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4082405/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>a</sup>Correlation coefficient</div><div id="TFN2"><sup>b</sup>Standard Error</div><div id="TFN3"><sup>c</sup>Effect estimate (odds ratio)</div><div id="TFN4"><sup>d</sup>Effect Allele Frequency</div><div id="TFN5"><sup>e</sup>Imputation accuracy</div></div></div></div><div id="S14" class="sec"><h3 id="S14title">Meta-analysis of ProtecT and UKGPCS studies (stage 2)</h3><p id="P21" class="p p-first-last">All SNPs at P&lt;5 × 10<sup>−5</sup> in ProtecT were meta-analysed with results from the UKGPCS. The total number of individuals included was 6241 (cases: ProtecT n=1146, UKGPCS n= 1854; controls: ProtecT n=1804, UKGPCS n=1437). A total of 175 SNPs reached genome wide significance (p &lt; 5×10<sup>−8</sup>) for an association with PrCa in the meta-analysis and were all located in or near genes across 4 previously identified loci (<a href="/pmc/articles/PMC4082405/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), with 6 independent signals. There was evidence of significant heterogeneity between the studies for the rs1447295 (8q24.21) marker (I<sup>2</sup>=86.1%, p-value for heterogeneity = 0.01). There was also evidence of moderate-high levels of heterogeneity for rs6983267, rs10993994 and rs17632542. The heterogeneity of rs6983267, rs10993994 and rs17632542 was greatly attenuated when the analysis was repeated using the ProtecT effect estimates from a restricted control population (low PSA controls &lt;0.5 ng/ml) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary table 3</a>). The heterogeneity observed for rs1447295, however, remained high (I<sup>2</sup>=83.1%, p-value for heterogeneity = 0.01). When the analysis was repeated using ProtecT effect estimates based on young and/or familial cases and low PSA controls, the heterogeneity was only slightly reduced and remained statistically significant (I<sup>2</sup>= 78%, p-value for heterogeneity = 0.03).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p9">Summary results of top independent SNPS in known loci associated with PrCa identified by meta-analysis of ProtecT with UKGPCS</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140300943011504" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="center"></th><th colspan="4" rowspan="1" valign="top" align="center">ProtecT</th><th colspan="4" rowspan="1" valign="top" align="center">UKGPCS</th><th colspan="5" rowspan="1" valign="top" align="center">Combined (Meta-Results)</th></tr><tr><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="left">Chrom<sup><sup>a</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="left">Position</th><th rowspan="1" colspan="1" valign="top" align="left">Gene</th><th rowspan="1" colspan="1" valign="top" align="center">EAF</th><th rowspan="1" colspan="1" valign="top" align="center">
β
</th><th rowspan="1" colspan="1" valign="top" align="center">SE</th><th rowspan="1" colspan="1" valign="top" align="center">EAF<sup><sup>b</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="center">P-value</th><th rowspan="1" colspan="1" valign="top" align="center">
β
</th><th rowspan="1" colspan="1" valign="top" align="center">SE</th><th rowspan="1" colspan="1" valign="top" align="center">EAF*</th><th rowspan="1" colspan="1" valign="top" align="center">P-value</th><th rowspan="1" colspan="1" valign="top" align="center">
β
</th><th rowspan="1" colspan="1" valign="top" align="center">(95% CI)</th><th rowspan="1" colspan="1" valign="top" align="center">P-value</th><th rowspan="1" colspan="1" valign="top" align="center">I^2<sup><sup>c</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="center">P-Het<sup><sup>d</sup></sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="middle" align="left">rs12682344</td><td rowspan="1" colspan="1" valign="middle" align="left">8</td><td rowspan="1" colspan="1" valign="middle" align="left">128175966</td><td rowspan="1" colspan="1" valign="middle" align="left"><em>SRRM1P1</em> -<em>POU5F1B</em></td><td rowspan="1" colspan="1" valign="middle" align="center">G</td><td rowspan="1" colspan="1" valign="middle" align="center">0.57</td><td rowspan="1" colspan="1" valign="middle" align="center">0.13</td><td rowspan="1" colspan="1" valign="middle" align="center">0.04</td><td rowspan="1" colspan="1" valign="middle" align="center">1.28 × 10<sup>−05</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.79</td><td rowspan="1" colspan="1" valign="middle" align="center">0.14</td><td rowspan="1" colspan="1" valign="middle" align="center">0.04</td><td rowspan="1" colspan="1" valign="middle" align="center">9.66 × 10<sup>−09</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.67</td><td rowspan="1" colspan="1" valign="middle" align="center">(0.48,0.86)</td><td rowspan="1" colspan="1" valign="middle" align="center">4.69 × 10<sup>−12</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">21.7%</td><td rowspan="1" colspan="1" valign="middle" align="center">0.26</td></tr><tr><td rowspan="1" colspan="1" valign="middle" align="left">rs6983267</td><td rowspan="1" colspan="1" valign="middle" align="left">8</td><td rowspan="1" colspan="1" valign="middle" align="left">128482487</td><td rowspan="1" colspan="1" valign="middle" align="left"><em>SRRM1P1</em> -<em>POU5F1B</em></td><td rowspan="1" colspan="1" valign="middle" align="center">G</td><td rowspan="1" colspan="1" valign="middle" align="center">0.22</td><td rowspan="1" colspan="1" valign="middle" align="center">0.05</td><td rowspan="1" colspan="1" valign="middle" align="center">0.52</td><td rowspan="1" colspan="1" valign="middle" align="center">4.25 × 10<sup>−05</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.36</td><td rowspan="1" colspan="1" valign="middle" align="center">0.05</td><td rowspan="1" colspan="1" valign="middle" align="center">0.53</td><td rowspan="1" colspan="1" valign="middle" align="center">2.30 × 10<sup>−12</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.29</td><td rowspan="1" colspan="1" valign="middle" align="center">(0.22,0.36)</td><td rowspan="1" colspan="1" valign="middle" align="center">4.04 × 10<sup>−15</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">72.0%</td><td rowspan="1" colspan="1" valign="middle" align="center">0.06</td></tr><tr><td rowspan="1" colspan="1" valign="middle" align="left">rs1447295</td><td rowspan="1" colspan="1" valign="middle" align="left">8</td><td rowspan="1" colspan="1" valign="middle" align="left">128554220</td><td rowspan="1" colspan="1" valign="middle" align="left"><em>POU5F1B</em> -<em>MYC</em></td><td rowspan="1" colspan="1" valign="middle" align="center">A</td><td rowspan="1" colspan="1" valign="middle" align="center">0.35</td><td rowspan="1" colspan="1" valign="middle" align="center">0.08</td><td rowspan="1" colspan="1" valign="middle" align="center">0.11</td><td rowspan="1" colspan="1" valign="middle" align="center">2.36 × 10<sup>−05</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.67</td><td rowspan="1" colspan="1" valign="middle" align="center">0.08</td><td rowspan="1" colspan="1" valign="middle" align="center">0.12</td><td rowspan="1" colspan="1" valign="middle" align="center">1.20 × 10<sup>−16</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.51</td><td rowspan="1" colspan="1" valign="middle" align="center">(0.40,0.63)</td><td rowspan="1" colspan="1" valign="middle" align="center">5.61 × 10<sup>−18</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">86.1%</td><td rowspan="1" colspan="1" valign="middle" align="center">0.01</td></tr><tr><td rowspan="1" colspan="1" valign="middle" align="left">rs10993994</td><td rowspan="1" colspan="1" valign="middle" align="left">10</td><td rowspan="1" colspan="1" valign="middle" align="left">51219502</td><td rowspan="1" colspan="1" valign="middle" align="left">
<em>MSMB</em>
</td><td rowspan="1" colspan="1" valign="middle" align="center">T</td><td rowspan="1" colspan="1" valign="middle" align="center">0.33</td><td rowspan="1" colspan="1" valign="middle" align="center">0.06</td><td rowspan="1" colspan="1" valign="middle" align="center">0.40</td><td rowspan="1" colspan="1" valign="middle" align="center">1.58 × 10<sup>−09</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.46</td><td rowspan="1" colspan="1" valign="middle" align="center">0.05</td><td rowspan="1" colspan="1" valign="middle" align="center">0.40</td><td rowspan="1" colspan="1" valign="middle" align="center">2.15 × 10<sup>−19</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.40</td><td rowspan="1" colspan="1" valign="middle" align="center">(0.33,0.47)</td><td rowspan="1" colspan="1" valign="middle" align="center">3.48 × 10<sup>−26</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">65.8%</td><td rowspan="1" colspan="1" valign="middle" align="center">0.09</td></tr><tr><td rowspan="1" colspan="1" valign="middle" align="left">rs4793529</td><td rowspan="1" colspan="1" valign="middle" align="left">17</td><td rowspan="1" colspan="1" valign="middle" align="left">66630231</td><td rowspan="1" colspan="1" valign="middle" align="left"><em>CALM2P1</em> -<em>SOX9</em></td><td rowspan="1" colspan="1" valign="middle" align="center">T</td><td rowspan="1" colspan="1" valign="middle" align="center">0.33</td><td rowspan="1" colspan="1" valign="middle" align="center">0.06</td><td rowspan="1" colspan="1" valign="middle" align="center">0.47</td><td rowspan="1" colspan="1" valign="middle" align="center">1.88 × 10<sup>−09</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.23</td><td rowspan="1" colspan="1" valign="middle" align="center">0.05</td><td rowspan="1" colspan="1" valign="middle" align="center">0.49</td><td rowspan="1" colspan="1" valign="middle" align="center">8.11 × 10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.28</td><td rowspan="1" colspan="1" valign="middle" align="center">(0.20,0.35)</td><td rowspan="1" colspan="1" valign="middle" align="center">1.78 × 10<sup>−13</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">49.8%</td><td rowspan="1" colspan="1" valign="middle" align="center">0.16</td></tr><tr><td rowspan="1" colspan="1" valign="middle" align="left">rs17632542</td><td rowspan="1" colspan="1" valign="middle" align="left">19</td><td rowspan="1" colspan="1" valign="middle" align="left">56053569</td><td rowspan="1" colspan="1" valign="middle" align="left">
<em>KLK3</em>
</td><td rowspan="1" colspan="1" valign="middle" align="center">T</td><td rowspan="1" colspan="1" valign="middle" align="center">0.60</td><td rowspan="1" colspan="1" valign="middle" align="center">0.11</td><td rowspan="1" colspan="1" valign="middle" align="center">0.91</td><td rowspan="1" colspan="1" valign="middle" align="center">1.28 × 10<sup>−08</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.82</td><td rowspan="1" colspan="1" valign="middle" align="center">0.08</td><td rowspan="1" colspan="1" valign="middle" align="center">0.89</td><td rowspan="1" colspan="1" valign="middle" align="center">4.74 × 10<sup>−23</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">0.73</td><td rowspan="1" colspan="1" valign="middle" align="center">(0.6,0.86)</td><td rowspan="1" colspan="1" valign="middle" align="center">2.34 × 10<sup>−28</sup></td><td rowspan="1" colspan="1" valign="middle" align="center">62.7%</td><td rowspan="1" colspan="1" valign="middle" align="center">0.10</td></tr></tbody></table></div><div id="largeobj_idm140300943011504" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4082405/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN6"><sup>a</sup>Chrom - Chromosome</div><div id="TFN7"><sup>b</sup>Effect Allele Frequency</div><div id="TFN8"><sup>c</sup>% of variation between study-specific effect estimates which is due to heterogeneity</div><div id="TFN9"><sup>d</sup>Tests the hypothesis that there is no difference in the study-specific effect estimates</div></div></div></div><div id="S15" class="sec sec-last"><h3 id="S15title">Stratified analysis using different control populations in ProtecT and PSA regressed in the unrestricted controls (stages 3 and 4)</h3><p id="P22" class="p p-first">Of the 81 SNPs examined, SNPs showing evidence of heterogeneity (p &lt; 0.05) in effect estimates quantifying the difference in risk between cases and low or high PSA controls, and/or SNPs that showed at least nominal association with PSA levels in unrestricted controls (p &lt; 0.05) are shown in <a href="/pmc/articles/PMC4082405/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>. When comparing cases with low PSA controls, alleles at the genetic markers rs1512268 (8p21.2), rs445114 (8q24.21), rs10788160 (10q26.12), rs11199874 (10q26.12), rs17632542 (19q13.33), rs266849 (19q13.33) and rs2735839 (19q13.33) were strongly associated with an increased risk of PrCa (all p≤0.01), with odds ratios ranging from 1.24 to 2.73. The effect-estimates, however, were attenuated to the null when using high PSA controls (p-values for heterogeneity between estimates all &lt;0.04). There was also some evidence of associations of these SNPs with PSA levels in the “unrestricted” control population (in particular, rs17632542 (19q19.33) associated with a 32% increase in PSA per allele), which suggests that the difference observed in the stratified analysis maybe explained by an association of these SNPs with PSA level. Only associations of the following SNPs with PSA levels were statistically significant (P≤0.05) in the “unrestricted” control population: rs445114, rs17632542, rs2735839 and rs266849. A further SNP (rs3850699) showed a similar association with PSA, with the effect estimate attenuating towards the null in the high PSA controls, but in the “unrestricted” control population the allele only increased PSA levels by 1% (p=0.73).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p10">Comparison of cases with supernormal or high PSA controls and PSA regressed on SNPs in unrestricted controls <sup><sup>*</sup></sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140300937721360" class="xtable"><table frame="below" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th colspan="5" rowspan="1" valign="middle" align="center">Stratified analysis comparing cases with two different control groups</th><th colspan="3" rowspan="1" valign="middle" align="center">PSA regressed on SNPs in unrestricted controls (n=1272)</th></tr><tr><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th colspan="2" rowspan="1" valign="middle" align="center">Low PSA controls (n=770)</th><th colspan="2" rowspan="1" valign="middle" align="center">High PSA controls(n=93)</th><th rowspan="2" colspan="1" valign="middle" align="center">
<em>p het</em>
<sup><sup>b</sup></sup>
</th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th><th rowspan="1" colspan="1" valign="middle" align="left"></th></tr><tr><th rowspan="1" colspan="1" valign="middle" align="left">Chrom<sup><sup>a</sup></sup></th><th rowspan="1" colspan="1" valign="middle" align="center">SNP</th><th rowspan="1" colspan="1" valign="middle" align="center">Putative Gene</th><th rowspan="1" colspan="1" valign="middle" align="left">Risk Allele</th><th rowspan="1" colspan="1" valign="middle" align="left">OR (SE)</th><th rowspan="1" colspan="1" valign="middle" align="left">
<em>p</em>
</th><th rowspan="1" colspan="1" valign="middle" align="left">OR (SE)</th><th rowspan="1" colspan="1" valign="middle" align="left">
<em>p</em>
</th><th rowspan="1" colspan="1" valign="middle" align="right">
β
</th><th rowspan="1" colspan="1" valign="middle" align="left">% PSA Change</th><th rowspan="1" colspan="1" valign="middle" align="right">
<em>p</em>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">3</td><td rowspan="1" colspan="1" valign="top" align="center">189311171</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>CTDSPL</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">T</td><td rowspan="1" colspan="1" valign="top" align="left">1.07 (0.10)</td><td rowspan="1" colspan="1" valign="top" align="right">0.49</td><td rowspan="1" colspan="1" valign="top" align="left">1.79 (0.34)</td><td rowspan="1" colspan="1" valign="top" align="right">0.002</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td><td rowspan="1" colspan="1" valign="top" align="right">−0.09</td><td rowspan="1" colspan="1" valign="top" align="right">−9%</td><td rowspan="1" colspan="1" valign="top" align="right">0.04</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">3</td><td rowspan="1" colspan="1" valign="top" align="center">rs7611694</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>SIDT1</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">A</td><td rowspan="1" colspan="1" valign="top" align="left">1.09 (0.63)</td><td rowspan="1" colspan="1" valign="top" align="right">0.19</td><td rowspan="1" colspan="1" valign="top" align="left">0.87 (0.19)</td><td rowspan="1" colspan="1" valign="top" align="right">0.40</td><td rowspan="1" colspan="1" valign="top" align="right">0.17</td><td rowspan="1" colspan="1" valign="top" align="right">0.07</td><td rowspan="1" colspan="1" valign="top" align="right">8%</td><td rowspan="1" colspan="1" valign="top" align="right">0.02</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">5</td><td rowspan="1" colspan="1" valign="top" align="center">rs6869841</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>FAM44B (BOD1)</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">T</td><td rowspan="1" colspan="1" valign="top" align="left">1.35 (0.11)</td><td rowspan="1" colspan="1" valign="top" align="right">3.44×10<sup>−4</sup></td><td rowspan="1" colspan="1" valign="top" align="left">1.22 (0.24)</td><td rowspan="1" colspan="1" valign="top" align="right">0.29</td><td rowspan="1" colspan="1" valign="top" align="right">0.63</td><td rowspan="1" colspan="1" valign="top" align="right">0.08</td><td rowspan="1" colspan="1" valign="top" align="right">9%</td><td rowspan="1" colspan="1" valign="top" align="right">0.03</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">6</td><td rowspan="1" colspan="1" valign="top" align="center">rs1983891</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>FOXP4</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">T</td><td rowspan="1" colspan="1" valign="top" align="left">1.10 (0.08)</td><td rowspan="1" colspan="1" valign="top" align="right">0.22</td><td rowspan="1" colspan="1" valign="top" align="left">0.96 (0.16)</td><td rowspan="1" colspan="1" valign="top" align="right">0.80</td><td rowspan="1" colspan="1" valign="top" align="right">0.43</td><td rowspan="1" colspan="1" valign="top" align="right">0.08</td><td rowspan="1" colspan="1" valign="top" align="right">8%</td><td rowspan="1" colspan="1" valign="top" align="right">0.03</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">rs1512268</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>SLC25A37 -NKX3-1</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">T</td><td rowspan="1" colspan="1" valign="top" align="left">1.30 (0.09)</td><td rowspan="1" colspan="1" valign="top" align="right">9.51×10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="left">0.83 (0.13)</td><td rowspan="1" colspan="1" valign="top" align="right">0.24</td><td rowspan="1" colspan="1" valign="top" align="right">0.004</td><td rowspan="1" colspan="1" valign="top" align="right">0.06</td><td rowspan="1" colspan="1" valign="top" align="right">6%</td><td rowspan="1" colspan="1" valign="top" align="right">0.07</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">rs445114</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>SRRM1P1 -POU5F1B</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">T</td><td rowspan="1" colspan="1" valign="top" align="left">1.46 (0.10)</td><td rowspan="1" colspan="1" valign="top" align="right">8.15×10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="left">0.92 (0.16)</td><td rowspan="1" colspan="1" valign="top" align="right">0.60</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td><td rowspan="1" colspan="1" valign="top" align="right">0.08</td><td rowspan="1" colspan="1" valign="top" align="right">8%</td><td rowspan="1" colspan="1" valign="top" align="right">0.03</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">rs6983267</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>SRRM1P1 -POU5F1B</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">G</td><td rowspan="1" colspan="1" valign="top" align="left">1.29 (0.05)</td><td rowspan="1" colspan="1" valign="top" align="right">8.51×10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="left">1.15 (0.13)</td><td rowspan="1" colspan="1" valign="top" align="right">0.36</td><td rowspan="1" colspan="1" valign="top" align="right">0.44</td><td rowspan="1" colspan="1" valign="top" align="right">0.08</td><td rowspan="1" colspan="1" valign="top" align="right">9%</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">10</td><td rowspan="1" colspan="1" valign="top" align="center">rs11199874</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>RPL19P16 - FGFR2</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">A</td><td rowspan="1" colspan="1" valign="top" align="left">1.24 (0.06)</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td><td rowspan="1" colspan="1" valign="top" align="left">0.78 (0.21)</td><td rowspan="1" colspan="1" valign="top" align="right">0.14</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td><td rowspan="1" colspan="1" valign="top" align="right">0.07</td><td rowspan="1" colspan="1" valign="top" align="right">7%</td><td rowspan="1" colspan="1" valign="top" align="right">0.07</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">10</td><td rowspan="1" colspan="1" valign="top" align="center">rs10788160</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>RPL19P16 - FGFR2</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">A</td><td rowspan="1" colspan="1" valign="top" align="left">1.24 (0.06)</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td><td rowspan="1" colspan="1" valign="top" align="left">0.80 (0.21)</td><td rowspan="1" colspan="1" valign="top" align="right">0.18</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td><td rowspan="1" colspan="1" valign="top" align="right">0.06</td><td rowspan="1" colspan="1" valign="top" align="right">6%</td><td rowspan="1" colspan="1" valign="top" align="right">0.08</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">10</td><td rowspan="1" colspan="1" valign="top" align="center">rs3850699</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>TRIM8</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">A</td><td rowspan="1" colspan="1" valign="top" align="left">1.17 (0.06)</td><td rowspan="1" colspan="1" valign="top" align="right">0.03</td><td rowspan="1" colspan="1" valign="top" align="left">0.82 (0.22)</td><td rowspan="1" colspan="1" valign="top" align="right">0.28</td><td rowspan="1" colspan="1" valign="top" align="right">0.048</td><td rowspan="1" colspan="1" valign="top" align="right">0.01</td><td rowspan="1" colspan="1" valign="top" align="right">1%</td><td rowspan="1" colspan="1" valign="top" align="right">0.73</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">10</td><td rowspan="1" colspan="1" valign="top" align="center">rs10993994</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>MSMB</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">T</td><td rowspan="1" colspan="1" valign="top" align="left">1.61 (0.11)</td><td rowspan="1" colspan="1" valign="top" align="right">4.54×10<sup>−12</sup></td><td rowspan="1" colspan="1" valign="top" align="left">1.45 (0.23)</td><td rowspan="1" colspan="1" valign="top" align="right">0.02</td><td rowspan="1" colspan="1" valign="top" align="right">0.51</td><td rowspan="1" colspan="1" valign="top" align="right">0.08</td><td rowspan="1" colspan="1" valign="top" align="right">8%</td><td rowspan="1" colspan="1" valign="top" align="right">0.02</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">13</td><td rowspan="1" colspan="1" valign="top" align="center">rs9600079</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>FABP5L1 - KLF12</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">G</td><td rowspan="1" colspan="1" valign="top" align="left">1.07 (0.06)</td><td rowspan="1" colspan="1" valign="top" align="right">0.33</td><td rowspan="1" colspan="1" valign="top" align="left">0.99 (0.16)</td><td rowspan="1" colspan="1" valign="top" align="right">0.97</td><td rowspan="1" colspan="1" valign="top" align="right">0.65</td><td rowspan="1" colspan="1" valign="top" align="right">0.06</td><td rowspan="1" colspan="1" valign="top" align="right">6%</td><td rowspan="1" colspan="1" valign="top" align="right">0.048</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">rs17632542</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>KLK3</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">T</td><td rowspan="1" colspan="1" valign="top" align="left">2.73 (032)</td><td rowspan="1" colspan="1" valign="top" align="right">1.40×10<sup>−17</sup></td><td rowspan="1" colspan="1" valign="top" align="left">0.76 (0.27)</td><td rowspan="1" colspan="1" valign="top" align="right">0.44</td><td rowspan="1" colspan="1" valign="top" align="right">1.94 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" valign="top" align="right">0.28</td><td rowspan="1" colspan="1" valign="top" align="right">32%</td><td rowspan="1" colspan="1" valign="top" align="right">5.49×10<sup>−7</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">rs2735839</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>KLK3 - KLK2</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">G</td><td rowspan="1" colspan="1" valign="top" align="left">2.13 (0.20)</td><td rowspan="1" colspan="1" valign="top" align="right">1.90×10<sup>−16</sup></td><td rowspan="1" colspan="1" valign="top" align="left">1.29 (0.28)</td><td rowspan="1" colspan="1" valign="top" align="right">0.26</td><td rowspan="1" colspan="1" valign="top" align="right">0.02</td><td rowspan="1" colspan="1" valign="top" align="right">0.21</td><td rowspan="1" colspan="1" valign="top" align="right">23%</td><td rowspan="1" colspan="1" valign="top" align="right">0.004</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">rs266849</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>KLK15 -KLK3</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">A</td><td rowspan="1" colspan="1" valign="top" align="left">1.76 (0.05)</td><td rowspan="1" colspan="1" valign="top" align="right">8.62×10<sup>−12</sup></td><td rowspan="1" colspan="1" valign="top" align="left">1.15 (0.17)</td><td rowspan="1" colspan="1" valign="top" align="right">0.49</td><td rowspan="1" colspan="1" valign="top" align="right">0.03</td><td rowspan="1" colspan="1" valign="top" align="right">0.12</td><td rowspan="1" colspan="1" valign="top" align="right">13%</td><td rowspan="1" colspan="1" valign="top" align="right">2.40×10<sup>−6</sup></td></tr></tbody></table></div><div id="largeobj_idm140300937721360" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4082405/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN10"><sup>*</sup>SNPs showing evidence of heterogeneity (p &lt; 0.05) in effect estimates quantifying the difference in risk between cases and low or high PSA controls, and/or SNPs that showed at least nominal association with PSA levels in unrestricted controls (p &lt; 0.05).</div><div id="TFN11"><sup>a</sup>Chrom - Chromosome</div><div id="TFN12"><sup>b</sup>Tests the hypothesis that there is no difference between the effect estimate of the cases vs. low PSA controls and cases vs. high PSA controls</div></div></div><p id="P23">There was also evidence that a further six SNP alleles (rs7611694, rs6869841, rs1983891, rs6983267, rs10993994 and rs9600079) were associated with increasing circulating PSA level (p&lt;0.05), and that the use of high PSA controls attenuated effect estimates of these SNPs with PrCa towards the null. The difference in estimates, however, was not significant (all p-values&gt;0.4). Relaxing the high PSA threshold to ≥2 ng/ml, we observed a statistically significant difference when comparing the estimates generated using low vs. high PSA controls for rs6869841-T (p=0.01) and rs10993994-T (p=0.04) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary table 4</a>).</p><p id="P24" class="p p-last">The T-allele at 3p22.2 (rs9311171) was associated with a more pronounced increase in risk of PrCa when cases were compared with high PSA controls (79% increase) as opposed to low PSA controls (7% increase) (p-value for heterogeneity = 0.01). There was also evidence of an association between the rs9311171-T allele and decreased PSA levels (p=0.035). In the sensitivity analysis (high PSA controls ≥2ng/ml), rs4775302 (15q21.1) was associated with a larger increase in risk of PrCa when cases were compared to the high PSA controls (29% increase), as opposed to the low PSA controls (2% increase) (p-value for heterogeneity=0.03) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary table 4</a>). This was supported by the regression analysis of PSA in the “unrestricted” control population, which showed an association in the opposite direction (5% decrease p=0.09).</p></div></div><div id="S16" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S16title">Discussion</h2><p id="P25" class="p p-first">Our GWAS and meta-analysis replicate previous findings for the following loci: 10q11.23 (rs10993994 - <em>MSMB</em>), 17q24.3 (rs7222314 - <em>CALM2P1 - SOX9</em>) and 19q13.33(rs1058205 - <em>KLK3</em>) in the ProtecT GWAS; and 8q24.21 (rs12682344,rs6983267 and rs1447295 - intergenic), 10q11.23 (rs10993994 - <em>MSMB</em>), 17q24.3 (rs4793529 - <em>CALM2P1 - SOX9</em>)and 19q13.33 (rs17632542 –<em>KLK3</em>) in the meta-analysis. We also demonstrated a novel association of one SNP with circulating PSA level: rs9311171-T (inversely associated with PSA). The allele at the genetic marker rs9311171 is located near a microRNA (<em>MIR26A1</em>) and a protein linked to oncogenesis (<em>CTDSPL</em>). This SNP (rs9311171) had a larger positive association with PrCa when cases were compared with high PSA, as opposed to low PSA controls. This suggests that this marker is directly associated with both PSA level and PrCa risk.</p><p id="P26" class="p">We also found evidence that the association of PrCa risk of seven other SNPs at loci 8p21.2, 10q26.12, and 19q13.33 could be confounded by the variant-PSA association(rs1512268-T, rs10788160-A, rs445114-T, rs11199874-A, rs17632542-T, rs2735839-G and rs266849-A). The association between PrCa and the respective SNP allele was present in the comparison of cases with low-PSA controls, but this association disappeared when compared to high-PSA controls. There was also evidence of associations between these SNPs and PSA levels in the “unrestricted” control population. Associations of rs1512268-T, rs10788160-A and rs11199874-A with PSA levels were only statistically significant (p&lt;0.05) in the stratified analysis. Whilst associations of SNPs with PSA levels were not statistically significant in the regression analysis, the direction of the effect provides some support for the conclusion that these SNP alleles are associated with increased circulating PSA level. Eeles <em>et al</em> (2009)(<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381148">5</a>) and Gudmundsson <em>et al</em>(2010) (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794935">19</a>) previously observed a positive association of PSA with rs1512268-T (near <em>NKX3.1</em>) and rs10788160-A (<em>FGFR2</em>), respectively. The allele at the genetic marker rs445114 (intergenic) was previously shown to have a positive association with PSA level, albeit non-genome wide significant (p=1.27 × 10<sup>−2</sup>)(<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794942">19</a>). This is consistent with the findings of Al Olama <em>et al</em> (2009)(<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381137">18</a>), who found that a SNP (rs620861) in strong linkage disequilibrium with rs445114 was positively associated with PSA level (p=4.8 × 10<sup>−8</sup>).Whilst rs11199874-A has not previously been tested for a relationship with PSA, it is in strong linkage disequilibrium with rs10788160-A (r<sup>2</sup>=0.94) (<em>FGFR2</em>), which has been shown to be associated with increasing PSA levels. Our analysis suggests that rs10788160-A is associated with higher PSA levels, whilst rs10788160-G is associated with lower levels. A previous study reported a positive association between rs11199874-G and PrCa (<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381145">25</a>). This association could be driven by the large proportion (&gt;50%) of high PSA (4-10 ng/ml) controls used rather than reflecting a true association because this high PSA enriched control sample is likely to have a higher proportion of individuals with the allele rs11199874-A; this could in turn account for the positive association of PrCa with rs11199874-G (the opposite allele to rs11199874-A). Two markers, in strong linkage disequilibrium (rs17632542-T and rs2735839-G), located near the kallikrein-related peptidase protein coding genes, have previously been observed to be positively associated with PSA level (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_480794940">19</a>). SNP rs266849 is also located near, but is independent of this set of PSA- associated proteins; a previous study reported no association of rs266849 with PSA in controls with a PSA &lt;10ng/ml (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381139">6</a>). When we reduced our threshold for defining high PSA controls (PSA≥2 ng/ml) in the stratified analysis, we observed similar findings in the same direction to those that were found to be significant using the higher PSA threshold (PSA≥3ng/ml). In addition, in this sensitivity analysis three other SNPs were shown to be associated with PSA.</p><div id="S17" class="sec"><h3 id="S17title">Impact of control selection</h3><p id="P27" class="p p-first-last">Our analysis suggests that the selection of controls for GWAS below a certain PSA threshold results in associations with PrCa, when the actual association is with PSA level (e.g. rs6869841). Additionally, the selection of these controls can lead to the masking of a PrCa association (e.g. rs9311171). To avoid these difficulties, an optimal design for a GWAS would be to select controls who have PSA levels at or above the threshold for biopsy, and who are biopsy negative. These criteria ensure that the cases and controls are comparable in terms of PSA level and therefore associations of SNP markers with PrCa are not confounded by associations with PSA.</p></div><div id="S18" class="sec sec-last"><h3 id="S18title">Strengths and limitations</h3><p id="P28" class="p p-first">This study was based on a population sample of men who underwent PSA testing, providing findings relevant to screen-detected cancer, and controls that were not selected according to PSA level. We also conducted a meta-analysis using 6241 individuals (3000 cases and 3241 controls), but we were only able to confirm previous GWAS findings rather than show novel associations. There was significant heterogeneity between the ProtecT and UKGPCS studies for associations of markers at 8q24.21, 10q11.23 and 19q13.33 with PrCa. These differences were partly explained by the difference in control ascertainment between studies (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary table 3</a>). We were, however, unable to explain the substantial heterogeneity (I<sup>2</sup>=78%) for rs1447295. We had a relatively small number of high PSA controls (n=93), so our stratified analysis will have been underpowered, explaining why we were unable to detect some previously published associations of SNPs with PSA. To increase power we carried out a sensitivity analysis by relaxing the high PSA control threshold to ≥2ng/ml (n=250), which resulted in 3 additional SNPs being associated with PSA level (rs6869841, rs10993994 and rs4775302).</p><p id="P29" class="p p-last">To avoid potential false positive results arising from multiple comparisons, we only highlight findings which showed evidence of an association in both the stratified and regression analyses. A Bonferroni corrected threshold significance level is a p-value of ≤ 0.0006(0.05/81 tests). However, this correction assumes that the tests were independent of each other, which in this case may not be true because some SNPs were correlated. Hence a rigid application of the Bonferroni corrected p-value could lead to an erroneous rejection of genuine loci (false-negatives). Nevertheless, we have presented exact p-values, allowing comparison with the Bonferroni corrected p-value. Whilst all controls with an elevated PSA level were biopsy negative, there is the possibility that some controls with a PSA level &lt;3ng/ml had undetected PrCa, as evidenced by a study (2004)(<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381161">1</a>) showing that 14% of men with a PSA level ≤3ng/ml had PrCa. The majority of controls in our study had a PSA level ≤1ng/ml, which was associated with less than a 9% chance of undetected PrCa (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381134">1</a>). It is also possible that up to a quarter of men with an elevated PSA level (≥3ng/ml) and a negative biopsy had undetected PrCa (<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_387381135">26</a>), which could explain why we did not observe associations of SNPs with PrCa when using the high PSA control group.</p></div></div><div id="S19" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">Conclusion</h2><p id="P30" class="p p-first-last">We have confirmed associations of PrCa risk with four previously identified loci (8q24.21,10q11.23, 17q24.3 and 19q13.33) and associations of seven markers with PSA level. We also found new evidence of an association of genetic variation at 3p22.2 with circulating PSA levels. We have highlighted that the method of selecting controls in case-control studies of associations of genetic variation with prostate cancer can influence the results suggesting that inferences made in these studies should carefully consider control selection.</p></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d36e718"><a href="/pmc/articles/PMC4082405/bin/NIHMS58112-supplement-1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(700K, pdf)</sup></div></div></div><div id="S20" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S20title">Acknowledgments</h2><div class="sec"><p id="__p1">The authors thank the tremendous contribution of all members of the ProtecT study research group, and especially the following who were involved in this research (Athene Lane, Prasad Bollina, Sue Bonnington, Lynn Bradshaw, James Catto, Debbie Cooper, Michael Davis, Liz Down, Andrew Doble, Alan Doherty, Garrett Durkan, Emma Elliott, David Gillatt, Pippa Herbert, Peter Holding, Joanne Howson, Mandy Jones, Roger Kockelbergh, Howard Kynaston, Teresa Lennon, Norma Lyons, Hing Leung, Malcolm Mason, Hilary Moody, Philip Powell, Alan Paul, Stephen Prescott, Derek Rosario, Patricia O’Sullivan, Pauline Thompson, Sarah Tidball). We thank Gemma Marsden, who processed the blood samples at the biorepository and Dr Chris Metcalfe for providing statistical advice. We also would like to thank the Center National de Genotypage, Evry, France for genotyping the ProtecT samples.</p><p id="__p2">Financial Support: The ProtecT study is funded by the U.K. Health Technology Assessment (HTA) Programme of the NIH Research (HTA 96/20/99; ISRCTN20141297). D.W. Knipe is funded by the Wellcome Trust 4-year studentship (WT099874MA). D.M. Evans, J.P. Kemp, G. Davey-Smith, and R.M. Martin work in an MRC Unit that is supported by the UK Medical Research Council (MC_UU_12013/1-9) and the University of Bristol. D. F. Easton is supported by a Cancer Research UK Grant (C1287/A10118). R.A. Eeles and Z.Kote-Jarai are supported by Cancer Research UK Grant (C5047/A7357) and support from the NIHR to the Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust. J. F.C. Hamdy, D.E. Neal, and J.L. Donovan are NIHR Senior Investigators. The authors thank the provision of the additional epidemiological data by the NHS R&amp;D Directorate supported Prodigal study and the ProMPT (Prostate Mechanisms of Progression and Treatment) collaboration which is supported by the National Cancer Research Institute (NCRI) formed by the Department of Health, the Medical Research Council and Cancer Research UK (G0500966/75466).</p></div></div><div id="idm140300945447408" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140300945447408title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"></p><p id="P31" class="p p-first"><strong>Conflict of Interest</strong></p><p id="P32" class="p p-last">The authors declare no conflicts of interest</p><p></p></div></div><div id="idm140300936065328" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140300936065328title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al.  Prevalence of prostate cancer among men with a prostate-specific antigen level &lt; or =4.0 ng per milliliter. <span><span class="ref-journal">N Engl J Med. </span>2004 May 27;<span class="ref-vol">350</span>:2239–46.</span> [<a href="/pubmed/15163773" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Prevalence+of+prostate+cancer+among+men+with+a+prostate-specific+antigen+level+<+or+=4.0+ng+per+milliliter&amp;author=IM+Thompson&amp;author=DK+Pauler&amp;author=PJ+Goodman&amp;author=CM+Tangen&amp;author=MS+Lucia&amp;volume=350&amp;publication_year=2004&amp;pages=2239-46&amp;pmid=15163773&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Eeles RA, Al Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. <span><span class="ref-journal">Nat Genet. </span>2013 Apr;<span class="ref-vol">45</span>:385–91.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3832790/">PMC free article</a>]</span> [<a href="/pubmed/23535732" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Identification+of+23+new+prostate+cancer+susceptibility+loci+using+the+iCOGS+custom+genotyping+array&amp;author=RA+Eeles&amp;author=AA+Al+Olama&amp;author=S+Benlloch&amp;author=EJ+Saunders&amp;author=DA+Leongamornlert&amp;volume=45&amp;publication_year=2013&amp;pages=385-91&amp;pmid=23535732&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Cheng I, Chen GK, Nakagawa H, He J, Wan P, Laurie CC, et al.  Evaluating Genetic Risk for Prostate Cancer among Japanese and Latinos. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2012 Nov;<span class="ref-vol">21</span>:2048–58.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3494732/">PMC free article</a>]</span> [<a href="/pubmed/22923026" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Evaluating+Genetic+Risk+for+Prostate+Cancer+among+Japanese+and+Latinos&amp;author=I+Cheng&amp;author=GK+Chen&amp;author=H+Nakagawa&amp;author=J+He&amp;author=P+Wan&amp;volume=21&amp;publication_year=2012&amp;pages=2048-58&amp;pmid=22923026&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, et al.  Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. <span><span class="ref-journal">J Natl Cancer Inst. </span>2007 Dec 19;<span class="ref-vol">99</span>:1836–44.</span> [<a href="/pubmed/18073375" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Two+genome-wide+association+studies+of+aggressive+prostate+cancer+implicate+putative+prostate+tumor+suppressor+gene+DAB2IP&amp;author=D+Duggan&amp;author=SL+Zheng&amp;author=M+Knowlton&amp;author=D+Benitez&amp;author=L+Dimitrov&amp;volume=99&amp;publication_year=2007&amp;pages=1836-44&amp;pmid=18073375&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, et al.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. <span><span class="ref-journal">Nat Genet. </span>2009 Oct;<span class="ref-vol">41</span>:1116–21.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2846760/">PMC free article</a>]</span> [<a href="/pubmed/19767753" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Identification+of+seven+new+prostate+cancer+susceptibility+loci+through+a+genome-wide+association+study&amp;author=RA+Eeles&amp;author=Z+Kote-Jarai&amp;author=AA+Al+Olama&amp;author=GG+Giles&amp;author=M+Guy&amp;volume=41&amp;publication_year=2009&amp;pages=1116-21&amp;pmid=19767753&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, et al.  Multiple newly identified loci associated with prostate cancer susceptibility. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:316–21.</span> [<a href="/pubmed/18264097" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Multiple+newly+identified+loci+associated+with+prostate+cancer+susceptibility&amp;author=RA+Eeles&amp;author=Z+Kote-Jarai&amp;author=GG+Giles&amp;author=AA+Olama&amp;author=M+Guy&amp;volume=40&amp;publication_year=2008&amp;pages=316-21&amp;pmid=18264097&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, et al.  Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. <span><span class="ref-journal">Nat Genet. </span>2009 Oct;<span class="ref-vol">41</span>:1122–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3562712/">PMC free article</a>]</span> [<a href="/pubmed/19767754" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+and+replication+studies+identify+four+variants+associated+with+prostate+cancer+susceptibility&amp;author=J+Gudmundsson&amp;author=P+Sulem&amp;author=DF+Gudbjartsson&amp;author=T+Blondal&amp;author=A+Gylfason&amp;volume=41&amp;publication_year=2009&amp;pages=1122-6&amp;pmid=19767754&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. <span><span class="ref-journal">Nat Genet. </span>2007 May;<span class="ref-vol">39</span>:631–7.</span> [<a href="/pubmed/17401366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+identifies+a+second+prostate+cancer+susceptibility+variant+at+8q24&amp;author=J+Gudmundsson&amp;author=P+Sulem&amp;author=A+Manolescu&amp;author=LT+Amundadottir&amp;author=D+Gudbjartsson&amp;volume=39&amp;publication_year=2007&amp;pages=631-7&amp;pmid=17401366&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. <span><span class="ref-journal">Nat Genet. </span>2007 Aug;<span class="ref-vol">39</span>:977–83.</span> [<a href="/pubmed/17603485" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Two+variants+on+chromosome+17+confer+prostate+cancer+risk,+and+the+one+in+TCF2+protects+against+type+2+diabetes&amp;author=J+Gudmundsson&amp;author=P+Sulem&amp;author=V+Steinthorsdottir&amp;author=JT+Bergthorsson&amp;author=G+Thorleifsson&amp;volume=39&amp;publication_year=2007&amp;pages=977-83&amp;pmid=17603485&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, et al.  Sequence variants at 22q13 are associated with prostate cancer risk. <span><span class="ref-journal">Cancer Res. </span>2009 Jan 1;<span class="ref-vol">69</span>:10–5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2705898/">PMC free article</a>]</span> [<a href="/pubmed/19117981" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Sequence+variants+at+22q13+are+associated+with+prostate+cancer+risk&amp;author=J+Sun&amp;author=SL+Zheng&amp;author=F+Wiklund&amp;author=SD+Isaacs&amp;author=G+Li&amp;volume=69&amp;publication_year=2009&amp;pages=10-5&amp;pmid=19117981&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, Kawaguchi T, et al.  Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. <span><span class="ref-journal">Nat Genet. </span>2010 Sep;<span class="ref-vol">42</span>:751–4.</span> [<a href="/pubmed/20676098" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+identifies+five+new+susceptibility+loci+for+prostate+cancer+in+the+Japanese+population&amp;author=R+Takata&amp;author=S+Akamatsu&amp;author=M+Kubo&amp;author=A+Takahashi&amp;author=N+Hosono&amp;volume=42&amp;publication_year=2010&amp;pages=751-4&amp;pmid=20676098&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, et al.  Genome-wide association study identifies new prostate cancer susceptibility loci. <span><span class="ref-journal">Hum Mol Genet. </span>2011 Oct 1;<span class="ref-vol">20</span>:3867–75.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3168287/">PMC free article</a>]</span> [<a href="/pubmed/21743057" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Genome-wide+association+study+identifies+new+prostate+cancer+susceptibility+loci&amp;author=FR+Schumacher&amp;author=SI+Berndt&amp;author=A+Siddiq&amp;author=KB+Jacobs&amp;author=Z+Wang&amp;volume=20&amp;publication_year=2011&amp;pages=3867-75&amp;pmid=21743057&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, et al.  Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2011 Jun;<span class="ref-vol">20</span>:1196–203.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3111761/">PMC free article</a>]</span> [<a href="/pubmed/21467234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Genome-wide+association+study+identifies+a+genetic+variant+associated+with+risk+for+more+aggressive+prostate+cancer&amp;author=LM+FitzGerald&amp;author=EM+Kwon&amp;author=MP+Conomos&amp;author=S+Kolb&amp;author=SK+Holt&amp;volume=20&amp;publication_year=2011&amp;pages=1196-203&amp;pmid=21467234&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, et al.  Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. <span><span class="ref-journal">Nat Genet. </span>2011 Jun;<span class="ref-vol">43</span>:570–3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3102788/">PMC free article</a>]</span> [<a href="/pubmed/21602798" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+of+prostate+cancer+in+men+of+African+ancestry+identifies+a+susceptibility+locus+at+17q21&amp;author=CA+Haiman&amp;author=GK+Chen&amp;author=WJ+Blot&amp;author=SS+Strom&amp;author=SI+Berndt&amp;volume=43&amp;publication_year=2011&amp;pages=570-3&amp;pmid=21602798&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, et al.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. <span><span class="ref-journal">Nat Genet. </span>2011 Aug;<span class="ref-vol">43</span>:785–91.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3396006/">PMC free article</a>]</span> [<a href="/pubmed/21743467" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Seven+prostate+cancer+susceptibility+loci+identified+by+a+multi-stage+genome-wide+association+study&amp;author=Z+Kote-Jarai&amp;author=AA+Olama&amp;author=GG+Giles&amp;author=G+Severi&amp;author=J+Schleutker&amp;volume=43&amp;publication_year=2011&amp;pages=785-91&amp;pmid=21743467&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Nam RK, Zhang WW, Trachtenberg J, Seth A, Klotz LH, Stanimirovic A, et al.  Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer. <span><span class="ref-journal">Clin Cancer Res. </span>2009 Mar 1;<span class="ref-vol">15</span>:1787–93.</span> 2009. [<a href="/pubmed/19223501" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Utility+of+Incorporating+Genetic+Variants+for+the+Early+Detection+of+Prostate+Cancer&amp;author=RK+Nam&amp;author=WW+Zhang&amp;author=J+Trachtenberg&amp;author=A+Seth&amp;author=LH+Klotz&amp;volume=15&amp;publication_year=2009&amp;pages=1787-93&amp;pmid=19223501&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, et al.  Multiple loci identified in a genome-wide association study of prostate cancer. <span><span class="ref-journal">Nat Genet. </span>2008 Mar;<span class="ref-vol">40</span>:310–5.</span> [<a href="/pubmed/18264096" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Multiple+loci+identified+in+a+genome-wide+association+study+of+prostate+cancer&amp;author=G+Thomas&amp;author=KB+Jacobs&amp;author=M+Yeager&amp;author=P+Kraft&amp;author=S+Wacholder&amp;volume=40&amp;publication_year=2008&amp;pages=310-5&amp;pmid=18264096&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al.  Multiple loci on 8q24 associated with prostate cancer susceptibility. <span><span class="ref-journal">Nat Genet. </span>2009 Oct;<span class="ref-vol">41</span>:1058–60.</span> [<a href="/pubmed/19767752" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Multiple+loci+on+8q24+associated+with+prostate+cancer+susceptibility&amp;author=AA+Al+Olama&amp;author=Z+Kote-Jarai&amp;author=GG+Giles&amp;author=M+Guy&amp;author=J+Morrison&amp;volume=41&amp;publication_year=2009&amp;pages=1058-60&amp;pmid=19767752&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, et al.  Genetic correction of PSA values using sequence variants associated with PSA levels. <span><span class="ref-journal">Sci Transl Med. </span>2010 Dec 15;<span class="ref-vol">2</span>:62ra92.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3564581/">PMC free article</a>]</span> [<a href="/pubmed/21160077" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Genetic+correction+of+PSA+values+using+sequence+variants+associated+with+PSA+levels&amp;author=J+Gudmundsson&amp;author=S+Besenbacher&amp;author=P+Sulem&amp;author=DF+Gudbjartsson&amp;author=I+Olafsson&amp;volume=2&amp;publication_year=2010&amp;pages=62ra92&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Lane JA, Hamdy FC, Martin RM, Turner EL, Neal DE, Donovan JL. Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies. <span><span class="ref-journal">Eur J Cancer. </span>2010;<span class="ref-vol">46</span>:3095–101.</span> [<a href="/pubmed/21047592" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer&amp;title=Latest+results+from+the+UK+trials+evaluating+prostate+cancer+screening+and+treatment:+The+CAP+and+ProtecT+studies&amp;author=JA+Lane&amp;author=FC+Hamdy&amp;author=RM+Martin&amp;author=EL+Turner&amp;author=DE+Neal&amp;volume=46&amp;publication_year=2010&amp;pages=3095-101&amp;pmid=21047592&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Ohori M, Wheeler TM, Scardino PT. The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. <span><span class="ref-journal">Cancer. </span>1994;<span class="ref-vol">74</span>:104–14.</span> [<a href="/pubmed/7516262" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=The+New+American+Joint+Committee+on+Cancer+and+International+Union+Against+Cancer+TNM+classification+of+prostate+cancer.+Clinicopathologic+correlations&amp;author=M+Ohori&amp;author=TM+Wheeler&amp;author=PT+Scardino&amp;volume=74&amp;publication_year=1994&amp;pages=104-14&amp;pmid=7516262&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: Using Sequence and Genotype Data to Estimate Haplotypes and Unobserved Genotypes. <span><span class="ref-journal">Genet Epidemiol. </span>2010 Dec;<span class="ref-vol">34</span>:816–34.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3175618/">PMC free article</a>]</span> [<a href="/pubmed/21058334" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genet+Epidemiol&amp;title=MaCH:+Using+Sequence+and+Genotype+Data+to+Estimate+Haplotypes+and+Unobserved+Genotypes&amp;author=Y+Li&amp;author=CJ+Willer&amp;author=J+Ding&amp;author=P+Scheet&amp;author=GR+Abecasis&amp;volume=34&amp;publication_year=2010&amp;pages=816-34&amp;pmid=21058334&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Li Y, Willer C, Sanna S, Abecasis G. Genotype Imputation. <span><span class="ref-journal">Annual Review of Genomics and Human Genetics. </span>2009;<span class="ref-vol">10</span>:387–406.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2925172/">PMC free article</a>]</span> [<a href="/pubmed/19715440" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annual+Review+of+Genomics+and+Human+Genetics&amp;title=Genotype+Imputation&amp;author=Y+Li&amp;author=C+Willer&amp;author=S+Sanna&amp;author=G+Abecasis&amp;volume=10&amp;publication_year=2009&amp;pages=387-406&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. <span><span class="ref-journal">BMJ. </span>2003 Sep 6;<span class="ref-vol">327</span>:557–60.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC192859/">PMC free article</a>]</span> [<a href="/pubmed/12958120" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Measuring+inconsistency+in+meta-analyses&amp;author=JP+Higgins&amp;author=SG+Thompson&amp;author=JJ+Deeks&amp;author=DG+Altman&amp;volume=327&amp;publication_year=2003&amp;pages=557-60&amp;pmid=12958120&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Nam RK, Zhang W, Siminovitch K, Shlien A, Kattan MW, Klotz LH, et al.  New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. <span><span class="ref-journal">Cancer Biol Ther. </span>2011 Dec 1;<span class="ref-vol">12</span>:997–1004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3280918/">PMC free article</a>]</span> [<a href="/pubmed/22130093" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=New+variants+at+10q26+and+15q21+are+associated+with+aggressive+prostate+cancer+in+a+genome-wide+association+study+from+a+prostate+biopsy+screening+cohort&amp;author=RK+Nam&amp;author=W+Zhang&amp;author=K+Siminovitch&amp;author=A+Shlien&amp;author=MW+Kattan&amp;volume=12&amp;publication_year=2011&amp;pages=997-1004&amp;pmid=22130093&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Zackrisson B, Aus G, Lilja H, Lodding P, Pihl CG, Hugosson J. Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. <span><span class="ref-journal">Eur Urol. </span>2003 Apr;<span class="ref-vol">43</span>:327–32.</span> [<a href="/pubmed/12667711" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Urol&amp;title=Follow-up+of+men+with+elevated+prostate-specific+antigen+and+one+set+of+benign+biopsies+at+prostate+cancer+screening&amp;author=B+Zackrisson&amp;author=G+Aus&amp;author=H+Lilja&amp;author=P+Lodding&amp;author=CG+Pihl&amp;volume=43&amp;publication_year=2003&amp;pages=327-32&amp;pmid=12667711&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4082405&amp;issue-id=239822&amp;journal-id=358&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140300978493584title">Abstract</a></li><li><a href="#S6title">Introduction</a></li><li><a href="#S7title">Materials and Methods</a></li><li><a href="#S12title">Results</a></li><li><a href="#S16title">Discussion</a></li><li><a href="#S19title">Conclusion</a></li><li><a href="#SMtitle">Supplementary Material</a></li><li><a href="#S20title">Acknowledgments</a></li><li><a href="#idm140300945447408title">Footnotes</a></li><li><a href="#idm140300936065328title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4082405/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4082405/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4082405/pdf/emss-58112.pdf">PDF (1.0M)</a></li> | <li><a href="#" data-citationid="PMC4082405" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4082405%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4082405%2F&amp;text=Genetic%20variation%20in%20protein%20specific%20antigen%20detected%20prostate%20cancer%20and%20the%20effect%20of%20control%20selection%20on%20genetic%20association%20studies" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4082405%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="24753544" data-aiid="4082405" data-aid="4082405" data-iid="239822" data-domainid="358" data-domain="wtpa" data-accid="PMC4082405" data-md5="1514d3f8548011bc24dc2eeb428faa9f"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T12:05:36-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal104&amp;ncbi_phid=CE8B1601DD5693010000000006C303FD&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4082405%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=wtpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4082405/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>